• Home
  • PRODUCTS
  • Instruments
  • CellOPTIQ® platform

CellOPTIQ® platform

CLYDE BIOSCIENCES, CellOPTIQ®| The Three-in-One Assay

Provision of patch-clamp quality data in a medium-throughput format

Using standard 96 well plates and modern voltage sensitive optical sensors,
CellOPTIQ® answers research questions more swiftly and more thoroughly than any other system.

CellOPTIQ® combines the three cardinal measurements in cardiac safety assessments.
By measuring voltage, calcium and contraction in one experiment Clyde’s clients enjoy remarkable precision in their acquisition of data.
Replacing Multi-Electrode Array, Calcium Transient and Impedance Assays with one assay.

CellOPTIQ® offers significant cost advantages

CellOPTIQ® is an essential precursor to in vivo studies.

Studies using animal models are costly, time-consuming and ethically challenging.
In order to reduce the number of animal tests conducted, compounds should be assayed on CellOPTIQ® before going in vivo.

CellOPTIQ® Mixed Ion Channel Effects - Verapamil

CellOPTIQ® is able to show mixed ion channel effects.

In this example, Verapamil shows mixed Ion channel effects that negates the proarrhythmic risk.

Comparison of CellOPTIQ® to Other Assay Types

In a single assay, CellOPTIQ® can offer you all of the data generated in independent voltage, calcium and contractility assays on a wider variety of cell types and in a greater range of study protocols.

Beyond conventional boundaries,
we deliver a bold new paradigm.
  • iPSC technologyCONTACT

    Contact Information

    • Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)

    • Business Registration No.: 109-86-37282
    • CEO: Choongseong Han

    • Tel : +82-2-2088-8886
    • Fax: +82-2-2088-8884
    • E-mail : support@nexel.co.kr